Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07457021) titled 'A Study to Evaluate the Safety and Effectiveness of Perfluorohexyloctane Eye Drops on Treatment of Dry Eye Disease (DED) Related to Meibomian Gland Dysfunction (MGD)' on Feb. 27.

Study Type: Observational

Primary Sponsor: Xiamen Ophthalmology Center Affiliated to Xiamen University

Condition: Dry Eye Disease

Recruitment Status: Not recruiting

Date of First Enrollment: March 1, 2026

Target Sample Size: 2000

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07457021

Published by HT Digital Content Services with permission from Health Daily Digest....